OUR PRODUCTS

MOBILE APPS

GENERAL INFO

CABA

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Cabaletta Bio (CABA) Earnings Date & Reports

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CABA is expected to report earnings to fall 9.00% to -66 cents per share on November 12

Cabaletta Bio CABA Stock Earnings Reports

Q3'25

Est.

$-0.66

Q2'25

Missed

by $0.08

Q1'25

Missed

by $0.05

Q4'24

Missed

by $0.01

Q3'24

Missed

by $0.02

The last earnings report on August 07 showed earnings per share of -73 cents, missing the estimate of -64 cents. With 252.57K shares outstanding, the current market capitalization sits at 124.39M.

View a ticker or compare two or three

Compare

Earnings Traders Earnings Traders

Annualized Return+23%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

CABA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CABA
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CABA showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

2929 Arch Street

Phone

+1 267 759-3100

Employees

103

Web

https://www.cabalettabio.com